BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37076643)

  • 1. Early evaluation of severe immune checkpoint inhibitor-associated myocarditis: a real-world clinical practice.
    Tang X; Li Y; Huang H; Shi R; Shen LT; Qian WL; Yang ZG
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8345-8357. PubMed ID: 37076643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of global myocardium strain by CMR-feature tracking in immune checkpoint inhibitor-associated myocarditis.
    Zhao SH; Yun H; Chen CZ; Chen YY; Lin JY; Zeng MS; Liu TS; Pan CZ; Jin H
    Eur Radiol; 2022 Nov; 32(11):7657-7667. PubMed ID: 35567603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study.
    Zheng Y; Chen Z; Song W; Xu Y; Zhao Z; Sun Y; Wang Y; Geng X; Zhao J; Zhang X; Xu Y; Chan JSK; Tse G; Li G; Hong L; Liu T
    Cancer Med; 2024 May; 13(10):e7233. PubMed ID: 38752474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor-induced Myocarditis.
    Cadour F; Cautela J; Rapacchi S; Varoquaux A; Habert P; Arnaud F; Jacquier A; Meilhac A; Paganelli F; Lalevée N; Scemama U; Thuny F
    Radiology; 2022 Jun; 303(3):512-521. PubMed ID: 35230185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program.
    Naqash AR; Moey MYY; Cherie Tan XW; Laharwal M; Hill V; Moka N; Finnigan S; Murray J; Johnson DB; Moslehi JJ; Sharon E
    J Clin Oncol; 2022 Oct; 40(29):3439-3452. PubMed ID: 35658474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study.
    Xie X; Wang L; Li Y; Xu Y; Wu J; Lin X; Lin W; Mai Q; Chen Z; Zhang J; Xie Z; Qin Y; Liu M; Lu M; Luo B; Zhou C
    Front Immunol; 2022; 13():879900. PubMed ID: 35924238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of immune checkpoint inhibitor-related myocarditis: Retrospective experience of a single institution.
    Qin Y; Zhang T; Du Z; Chen S; Li Y; Lv Y; Du X; Hu Y; Liu Z
    Int Immunopharmacol; 2024 Jul; 136():112385. PubMed ID: 38850788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.
    Mahmood SS; Fradley MG; Cohen JV; Nohria A; Reynolds KL; Heinzerling LM; Sullivan RJ; Damrongwatanasuk R; Chen CL; Gupta D; Kirchberger MC; Awadalla M; Hassan MZO; Moslehi JJ; Shah SP; Ganatra S; Thavendiranathan P; Lawrence DP; Groarke JD; Neilan TG
    J Am Coll Cardiol; 2018 Apr; 71(16):1755-1764. PubMed ID: 29567210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer].
    Ying YC; Tang Q; Yang KW; Mi Y; Fan Y; Yu W; Song Y; He ZS; Zhou LQ; Li XS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):644-651. PubMed ID: 35950386
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Boughdad S; Latifyan S; Fenwick C; Bouchaab H; Suffiotti M; Moslehi JJ; Salem JE; Schaefer N; Nicod-Lalonde M; Costes J; Perreau M; Michielin O; Peters S; Prior JO; Obeid M
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34686542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.
    Thavendiranathan P; Zhang L; Zafar A; Drobni ZD; Mahmood SS; Cabral M; Awadalla M; Nohria A; Zlotoff DA; Thuny F; Heinzerling LM; Barac A; Sullivan RJ; Chen CL; Gupta D; Kirchberger MC; Hartmann SE; Weinsaft JW; Gilman HK; Rizvi MA; Kovacina B; Michel C; Sahni G; González-Mansilla A; Calles A; Fernández-Avilés F; Mahmoudi M; Reynolds KL; Ganatra S; Gavira JJ; González NS; García de Yébenes Castro M; Kwong RY; Jerosch-Herold M; Coelho-Filho OR; Afilalo J; Zataraín-Nicolás E; Baksi AJ; Wintersperger BJ; Calvillo-Arguelles O; Ederhy S; Yang EH; Lyon AR; Fradley MG; Neilan TG
    J Am Coll Cardiol; 2021 Mar; 77(12):1503-1516. PubMed ID: 33766256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms based on ratio indexes to predict severity and prognosis in immune checkpoint inhibitors-related myocarditis: a retrospective analysis.
    Li Z; Yao T; Liu G; Guan Z; Liu J; Guo L; Ma J
    J Cancer Res Clin Oncol; 2024 May; 150(5):277. PubMed ID: 38801421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis.
    Awadalla M; Mahmood SS; Groarke JD; Hassan MZO; Nohria A; Rokicki A; Murphy SP; Mercaldo ND; Zhang L; Zlotoff DA; Reynolds KL; Alvi RM; Banerji D; Liu S; Heinzerling LM; Jones-O'Connor M; Bakar RB; Cohen JV; Kirchberger MC; Sullivan RJ; Gupta D; Mulligan CP; Shah SP; Ganatra S; Rizvi MA; Sahni G; Tocchetti CG; Lawrence DP; Mahmoudi M; Devereux RB; Forrestal BJ; Mandawat A; Lyon AR; Chen CL; Barac A; Hung J; Thavendiranathan P; Picard MH; Thuny F; Ederhy S; Fradley MG; Neilan TG
    J Am Coll Cardiol; 2020 Feb; 75(5):467-478. PubMed ID: 32029128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting.
    Moey MYY; Tomdio AN; McCallen JD; Vaughan LM; O'Brien K; Naqash AR; Cherry C; Walker PR; Carabello BA
    JACC CardioOncol; 2020 Sep; 2(3):491-502. PubMed ID: 34396256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategy for myocarditis in patients using immune checkpoint inhibitors or combined anti-vascular endothelial growth factor therapy by clinical severity.
    Liu Q; Yu Y; Lin J; Wang Y; Ai L; Li Q; Wu W; Jin H; Li S; Liu M; Yu S; Liu T
    Eur J Cancer; 2021 Nov; 157():10-20. PubMed ID: 34464781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic features of immune checkpoint inhibitor associated myocarditis.
    Zlotoff DA; Hassan MZO; Zafar A; Alvi RM; Awadalla M; Mahmood SS; Zhang L; Chen CL; Ederhy S; Barac A; Banerji D; Jones-O'Connor M; Murphy SP; Armanious M; Forrestal BJ; Kirchberger MC; Coelho-Filho OR; Rizvi MA; Sahni G; Mandawat A; Tocchetti CG; Hartmann S; Gilman HK; Zatarain-Nicolás E; Mahmoudi M; Gupta D; Sullivan R; Ganatra S; Yang EH; Heinzerling LM; Thuny F; Zubiri L; Reynolds KL; Cohen JV; Lyon AR; Groarke J; Thavendiranathan P; Nohria A; Fradley MG; Neilan TG
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series.
    Coustal C; Vanoverschelde J; Quantin X; Lesage C; Michot JM; Lappara A; Ederhy S; Assenat E; Faure M; Issa N; Lambotte O; Puyade M; Dereure O; Tosi D; Rullier P; Serre I; Larcher R; Klouche K; Chanques G; Vernhet-Kovacsik H; Faillie JL; Agullo A; Roubille F; Guilpain P; Maria ATJ
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37258037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis.
    Peleg Hasson S; Salwen B; Sivan A; Shamai S; Geva R; Merimsky O; Raphael A; Shmilovich H; Moshkovits Y; Kapusta L; Rozenbaum Z; Wolf I; Laufer-Perl M
    Clin Res Cardiol; 2021 Jan; 110(1):50-60. PubMed ID: 32296970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors.
    Awadalla M; Golden DLA; Mahmood SS; Alvi RM; Mercaldo ND; Hassan MZO; Banerji D; Rokicki A; Mulligan C; Murphy SPT; Jones-O'Connor M; Cohen JV; Heinzerling LM; Armanious M; Sullivan RJ; Damrongwatanasuk R; Chen CL; Gupta D; Kirchberger MC; Moslehi JJ; Shah SP; Ganatra S; Thavendiranathan P; Rizvi MA; Sahni G; Lyon AR; Tocchetti CG; Mercurio V; Thuny F; Ederhy S; Mahmoudi M; Lawrence DP; Groarke JD; Nohria A; Fradley MG; Reynolds KL; Neilan TG
    J Immunother Cancer; 2019 Feb; 7(1):53. PubMed ID: 30795818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated Myocarditis.
    Drobni ZD; Zafar A; Zubiri L; Zlotoff DA; Alvi RM; Lee C; Hartmann S; Gilman HK; Villani AC; Nohria A; Groarke JD; Sullivan RJ; Reynolds KL; Zhang L; Neilan TG
    J Am Heart Assoc; 2020 Dec; 9(23):e018306. PubMed ID: 33190570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.